Our study found that CD inhibits the NRP1 expression of both protein and mRNA levels in a dosage-dependent manner in various cancer cell lines, implying the therapeutic potential for anti-SARS-CoV-2 and anti-cancers. Here, NRP1 is linked to cancer.